Company Filing History:
2 out of 76 
1 out of 55 
1 out of 52 
Years Active: 1998-2015
Title: Helena Sandberg: Innovator in Recombinant Human Factors
Introduction
Helena Sandberg is a notable inventor based in Bromma, Sweden. She has made significant contributions to the field of biotechnology, particularly in the development of recombinant human factors. With a total of 4 patents, her work has advanced medical treatments and pharmaceutical compositions.
Latest Patents
Among her latest patents are two groundbreaking inventions. The first is titled "Recombinantly produced human factor VIII and IX," which involves a recombinant human factor VIII or IX protein that possesses a human glycosylation pattern while being devoid of N-glycolylneuraminic acid and/or the carbohydrate group Galα-3Gal. The second patent, "Stable factor VIII compositions," relates to a pharmaceutical composition that includes Factor VIII and divalent metal ions such as Zn and Cu. This composition is notable for its stability without the addition of albumin, and it outlines a method for producing recombinant Factor VIII from mammalian cells.
Career Highlights
Helena has worked with prominent companies in the biotechnology sector, including Pharmacia & Upjohn AB and Biovitrum AB. Her experience in these organizations has allowed her to refine her expertise and contribute to innovative solutions in her field.
Collaborations
Throughout her career, Helena has collaborated with talented individuals such as Anna-Lisa Smeds and Johanna Dalborg. These partnerships have fostered a creative environment that has led to significant advancements in her research.
Conclusion
Helena Sandberg's contributions to biotechnology, particularly in recombinant human factors, have made a lasting impact on the industry. Her innovative patents and collaborations highlight her dedication to advancing medical science.